| |
October 15, 2007 French TV channel, French 24, interviewed Dr. Ying Luo, CEO of Shanghai Genomics and GNI. The reporters also filmed the Company’s R&D laboratories.
October 15, 2007 The Documentary Channel of STV broadcast a TV series, “The Sky of Innovation”, which focuses on the Zhangjiang Hi-Tech Park. The TV series includes an interview with Dr. Ying Luo and introduction of the Company’s new drug development effort.
September 30,2007 The most recent issue of China Economic Review publishes an article about the outsourcing industry of life
sciences in China. Interviews with Dr. Christopher Savoie, Chairman and CEO of GNI, and Dr. Ying Luo, President and CEO of
Shanghai Genomics and COO of GNI, are included in the article.
November 25, 2006 Dr. Ying Luo, President and CEO of Shanghai Genomics, was interviewed by businessdocumentaries.com. He praised the environment for Hi-Tech industry in Shanghai, and especially at the dynamic Zhangjiang Hi-Tech Park. He is also optimistic for the future role of Hi-Tech in the economic development of Shanghai.
November 1, 2006 China Economic Review published a cover story, “Mother of Invention?”, describing the new government policy encouraging invention in China. Dr. Christopher Savoie, Chairman of Shanghai Genomics and CEO of GNI, and Dr. Ying Luo, CEO of Shanghai Genomics and President and COO of GNI, are quoted in the story. The drug discovery program in Shanghai is high-lighted.
July 31, 2006 Wall Street Reporter Magzine Inc. interviewed Dr. Ying Luo, CEO of Shanghai Genomics, as a follow-up of the initial interview in 2004. Dr. Luo updated the audience of the recent progress in product development and business development at Shanghai Genomics. He also described the future direction of Shanghai Genomics and GNI.
May 4,2006 A half-page article, “March of the mini-multinational”, was published on page 9 of London-
based Financial Times. The article claims that the business operation of GNI and Shanghai Genomics prove
that it no longer take great scale to straddle borders. Scientists from China, UK and Japan are working
together to find therapeutic solution for the benefit of all human being. The article lists the Do’s and
Don’ts for entrepreneur with international vision.
January 24, 2006 Yahoo News and PRWEB reported that Shanghai Genomics and Organon, the human healthcare business unit of Akzo Nobel，are to collaborate on a new research project. The collaboration, which will involve biological development work aimed at identification of more selective steroid hormone receptor modulators, will initially last for a period of two years. It extends Organon research interests in China and strengthens Shanghai Genomics’ international credentials. Shanghai Genomics’ integrated drug discovery platform and their expertise in nuclear receptor biology are crucial to the success of this collaboration.
October 7, 2005 Channel Documentary, Shanghai Television Station of Shanghai Media Group broadcasted a special 30-minute episode named “The Sky of Returnee”, on Dr. Ying Luo, CEO of Shanghai Genomics, about his unusual experience from his study in United State to the founding of Shanghai Genomics in China.
June 20, 2005 Yahoo reported the merger between GNI Ltd. and Shanghai Genomics. The combine of the Japanese and Chinese biotech companies is aimed for increasing R&D productivities and expanding market opportunities. Many international bio-pharmaceutical and financial media cited the report.
February 22, 2005 The Shanghai Biomedical Research Outsourcing Base and the Shanghai Pudong Biomedical Research Outsourcing Center are formally established in the Zhangjiang Hi-Tech Park of Pudong, Shanghai. Vice Mayor, Ms. Yan Junqi, participated the openning ceremony. Representing all biomedical research companies in the center, Dr. Ying Luo of Shanghai Genomics gave a speech at the cremoney. He pointed out that outsourcing is a major international trend. Chinese biotech industry should play a bigger role in this market. Shanghai media channels reported the event.
January 5,2005 Shanghai TV (STV) visited our company and interviewed the senior management returnee team. Video clips of the company's R&D operation was later broadcasted in the evening news.
November 10, 2004 Dr. Ying Luo, CEO of Shanghai Genomics and Mr. Huisheng Wang, Vice President of Shanghai Genomics were interviewed by the media group from Guang Zhou, China. Members of the media group include Press Office of Guangzhou Municipal Government, China News Service Guangzhou Branch, Nan Fang Daily, Guangzhou Daily and GZYV TV News Channel. The returnee team model was the focus of this interview.
July 28, 2004 Major German financial
newspaper, Handelsblatt, pulbished an article about
the roles of returnees in today's Chinese economy. The
article told several stories of the so called "sea
turtles", or returnees, coming back to China from
America or Europe to found new hi-tech companies in
Shanghai. Author of the article also compared the significant
improvement of investment environment in the last two
decades. Dr. Ying Luo was highlighted as a representative
of this group of "sea turtles".
July 26-August 1,2004 CHINA
DAILY Business Weekly published an article entitled"Firms
bite from outsourcing pie", introducing the importance
of outsourcing and the factors blocking Chinese biotech
progress. It takes Shanghai Genomics as a leader in
Chinese biotech/pharmaceutical industry to take outsourced
work, introducing our experience and achievements.
July 9,2004 Shanghai Jie Fang Daily
published an interview with the founder of Shanghai
Genomics, Dr. Jun Wu. The article is entitled "How
Does Shanghai Participate In The New Trend Of Drug Research
Outsourcing?". The article points out that winning
outsourced research work from international pharmaceutical
companies is an important path for Shanghai's biopharmaceutical
industry to grow. It also stated that Shanghai Genomics
is becoming a leading outsourcing center in Shanghai.
June 24,2004 Major domestic media of
China published the Chinese version of Forbes article,
introducing the outsoucing concept in drug research.
May 28,2004 The world famouse financial
magzine - FORBES, published an article on the trend
of outsourcing in the pharmaceutical industry. Through
interview with Mr. Epstein, financial consultant of
Shanghai Genomics, the article described how Shanghai
Genomics and other Indian companies become the major
representatives of Asian biotech/pharmaceutical industry
to take outsourced work from western world.
May 27,2004 Dr. Jun Wu, Chief Scientific
Officer and founder of Shanghai Genomics, was interviewd
over the phone by Biotech Today. Dr. Wu discussed the
company's technology platform and our strategy to build
a rich product pipeline in China. He specially talked
about the collaboaration with US and Japanese biotech
companies and our cutting edge research programs.
May 26,2004 Wall Street Reporter interviewed
Dr. Ying Luo, CEO of Shanghai Genomics over the phone.
Dr. Luo introduced the history and business model of
Shanghai Genomics to American audience. He specifically
pointed out that the Company has built a rich product
pipeline at a fraction of the cost in North America.
Research collaboration and fee-for-service has generated
steady revenue stream for the Company. Issues of IP
protection in China and overseas IPO were also discussed
in the interview.
May 2004 The major French economic
journal Enjeux Les Echos interviewed Dr. Alice Cai,
Senior Director at Shanghai Genomics, and reported in
a special coverage on Chinese High-Tech industry，Shanghai
Genomics’ rapid growth and its strength in bridging
biotech business between occident and orient.
March 7,2003 Dr. Sam Yi, Senior Director
of Business Development of Shanghai Genomics, was interviewed
by Macau Lotus Satellite TV. During the interview, Dr.
Yi commented on the entrepreneurial environment of Pudong,
Shanghai and the future development of Shanghai Genomics
June 17,2003 Dr. Sam Yi, Senior Director
of Business Development of Shanghai Genomics, was interviewed
by “Geometric”, a financial magazine published in Hong
Kong
June 15,2003 Sing Tao USA republished
the start-up history of Shanghai Genomics as a case
study of the wave of overseas scholars returning to
China
March 7,2003 Sing Tao Daily reported
from Singapore the start-up history of Shanghai Genomics
as a case study of the returning tide of overseas Chinese
scholars
March 6,2003 The Wall Street Journal
reported from New York on its front page the start-up
history of Shanghai Genomics
January 4,2003
Shanghai Job Market Newspaper reported that, after
being attracted by the excellent incubator environment
of Zhangjiang Hi-Tech Park, Shanghai Genomics founded
its business in the Park and is growing steadily
August 6,2002
One of Shanghai Genomics' webpages won the Concision
Award from First “BlueComm” Web Design Competition
August 2002 Video
replay of Shanghai Pudong New Area: Introduction of
Zhangjiang Hi-Tech Park and Shanghai Genomics ( rm,
4.12M,click to play ) 
July 12,2002 It is reported
by Shanghai Jie Fang Daily that Dr. Ying Luo, CEO of
Shanghai Genomics, became one of the returned overseas
talents who first received Shanghai Resident Card
March 28,2002 Shanghai Jie Fang Daily
reported the new model of entrepreneurship of returned
overseas scholars – "founding
business with team-based approach",
and cited Shanghai Genomics as one of the successful
cases
February 15,2002 Shanghai
Genomics and UCSD identified new signaling protein in
MAP kinase pathway and published results in Science
|
|
